π€― Stanford scientists have achieved a breakthrough! Mice with Type 1 Diabetes are now cured WITHOUT insulin or immune suppression. Incredible implications for the future of treatment!
#DiabetesResearch https://GigCityGeek.com/558459
Stanford Scientists Cure Type 1 Diabetes in Mice Without Insulin or Immune Suppression
An βimmune system resetβ eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at Stanford Medicine. Researchers say the strategy could also have potential for treating other autoimmune diseases and improving outcomes in organ transplantation. In a new study from Stanford Medici
𧬠Can molecular simulations transform the future of long-acting diabetes treatments?
π In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.11.007
π CSBJ: https://www.csbj.org/
#MolecularDynamics #DiabetesResearch #Biotherapeutics #GLP1 #Albumin #DrugDelivery #Biomaterials #ComputationalBiology #ProteinEngineering
π©Έ Today is
#WorldDiabetesDay!
π©Έ Last week, our scientific officer Klelia Salpea was at the European Parliament with EDENT1FI, the European Diabetes Forum (EUDF) and the Danish Presidency of the Council of the EU 2025 to present a series of recommendations for policymakers on how to fight
#type1diabetes.
π©Έ Watch the video of Klelia below and read the article for more:
https://lnkd.in/eGpy3T54#DiabetesResearch #Diabetes #IHITransformingHealth #EUResearch #HealthResearch #ItsInYourHands
AI revolutionising fight against cancer and diabetes | The-14
AI is transforming cancer and diabetes research by speeding drug discovery, predicting disease risk, and tailoring treatments for safer, more precise care.
Mounjaro is making headlines. We break down what this dual-action drug means for Indiaβs diabetic population, comparing its efficacy against existing treatments and its long-term viability.
https://www.linkedin.com/pulse/can-indias-diabetic-population-truly-benefit-from-new-arya-jain-4ebpc
#Mounjaro #DiabetesResearch #AffordableHealthcare #IndianHealthcare #DiabetesMedication
Diabetes Research Institute, Bascom Palmer Scientists Reveal How Diabetes Leads to Vision Loss - InventUM
A Diabetes Research Institute/Bascom Palmer collaboration resulted in a major step forward in understanding how diabetes damages vision.
Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d3937504e128">Bioresponsive materials have gained prominence as innovative tools for advancing drug
delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These
materials respond to biological stimuli such as pH, glucose, enzymes, or temperature,
thereby enabling spatiotemporally controlled drug release. This review examines recent
progress in the design strategies, activation mechanisms, and therapeutic applications
of these materials in diabetes care. Key focus areas include macromolecular insulin
delivery systems and oral hypoglycemic agents, with emphasis on their efficacy in
regulating blood glucose homeostasis. Despite their promise, challenges persist in
translating these technologies to clinical practice, including scalability limitations,
insufficient clinical validation, regulatory hurdles, and healthcare system compatibility.
Current therapeutic shortcomings, such as frequent injections and adverse effects
compromising patient adherence, are discussed. By synthesizing contemporary research
developments and implementation barriers, this work provides critical insights into
optimizing bioresponsive platforms for clinical translation. Our analysis underscores
the need for interdisciplinary approaches to address technical and practical constraints,
and ultimately engineer patient-centric, scalable solutions that enhance therapeutic
outcomes and quality of life. Future directions include bridging material innovation
with clinical needs to develop next-generation diabetes management systems.
</p>
π¬ 20 years ago: Finger pricks & guessing
2024: 3-year implantable sensors coming soon
β‘ Over-the-counter CGMs for non-diabetics
π§ AI nutrition recommendations
The blood sugar revolution is HERE
https://healthybloodsugarlevels.online/blood-sugar-studies
#BloodSugarStudies
#DiabetesResearch
#MedicalBreakthrough
#ClinicalTrials
#HealthScience
#MedicalStudies
#DiabetesScience
Medical Research on Blood Sugar Levels and Future Trends
Explore our comprehensive guide to medical studies on healthy blood sugar levels. We delve into research from 2000-2020, covering advancements, techniques, and future trends in glucose monitoring and diabetes management.
𧬠Breaking: Stem cell therapy for Type 1 diabetes showing 65-80% improvement rates in trials! Patients going from multiple daily insulin shots to little/no external insulin needed.
The future of diabetes treatment is here - learn about the groundbreaking research β
https://healthybloodsugarlevels.online/stem-cell-diabetes-therapy#StemCells #Diabetes #Type1Diabetes #MedicalBreakthrough #ClinicalTrials #DiabetesResearch #HealthTech #BetaCells #InsulinFree #DiabetesCure #MedicalInnovation #HealthcareStem Cell Therapy for Type 1 Diabetes: Complete Guide 2024 | Clinical Trials & Results
Discover breakthrough stem cell therapy for type 1 diabetes. Learn about mesenchymal stem cells, islet transplantation, clinical trial results, costs & how to access treatment in 2024.
Laronski
CSBJ
Innovative Health Initiative
The-14
MrMed : Online Pharmacy
Wisdom4theblind
ScienceOpen
marc hall
Academic Europe